Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
18 August 2021 | Story ANDRÉ DAMONS | Photo ANDRÉ DAMONS
Dr Osayande Evbuomwan, a Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine, always wanted to specialise in an area of medicine that was novel, innovative, intriguing and involved a lot of opportunities for groundbreaking research

Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine, Faculty of Health Sciences, at the University of the Free State (UFS) always wanted to specialize in an area of medicine that was novel, innovative, intriguing and involved many opportunities for groundbreaking research.

This passionate medical man, who joined the UFS in 2019, is behind his department using Lutetium 177 PSMA (Lu-177 PSMA) therapy to treatment metastatic castrate resistant prostate cancer (MCRPC) – an advanced stage prostate cancer. 
The UFS and the Free State province can now join other South African universities, like the University of Pretoria, University of the Witwatersrand, and other provinces in using this method to treat MCRPC patients. 

Built for this job

Dr Evbuomwan explains nuclear medicine is a medical specialty that involves the use of unsealed sources of radiation in the form of radioisotopes for the diagnosis and treatment of various disease conditions including cancers.
“It’s novelty and opportunity for research and ability to diagnose and treat disease conditions in one specialty attracted me to this field. I always wanted to be a doctor. I see it as a calling. It was also something my mum discovered while I was growing up as a child. In my next life, I would choose to be a medical doctor again,” he says.

“I was built for this job and it is always my joy to have the opportunity to carry out my work. We have been well-trained for this; we support all our skills with prayers. We try to give our patients the very best,” says Dr Evbuomwan, who is originally from Benin City, Edo state, Nigeria. 

After graduating as a nuclear medicine specialist from Wits University, Dr Evbuomwan moved to the City of Roses after a work opportunity opened. He saw it as an opportunity to showcase his talents.

“I have been privileged to receive training in this treatment during my residency training at Wits. I treated a few of these patients during my training and the results were amazing. The University of Pretoria has also been involved with this treatment, with some amazing results that are recognised worldwide. 

“This was enough to convince me to push for our department to also join the powerhouses and offer this treatment to patients who need it. With the influence of a very understanding head of department, Dr Gerrit Engelbrecht, we have been successful in pushing for the commencement of this treatment at our facility,” says Dr Evbuomwan.

Important treatment
According to him, the availability and expertise of Lutetium 177 PSMA (Lu-177 PSMA) therapy to treat MCRPC is very important for the Free State and the UFS, as it is able to offer an option for patients who do not qualify for available conventional treatment and/or who have failed the first line of conventional treatment. 

“In the majority of patients this treatment offers improved quality of life, disease-free progression and improved overall survival. It also alleviates the constant bone pains these patients have to go through daily. To be able to offer this treatment puts the university and the province on the map alongside other top institutions in and outside the country. It also offers opportunity for research,” says Dr Evbuomwan.

He believes with a PET/CT camera for proper staging of these patients with cancer the UFS would be able to expand the treatment of patients suffering from this deadly illness. Currently the university does not possess such a camera and has to use lesser methods in identifying the right patients for this therapy.

News Archive

UFS implements B Ed degree on Qwaqwa campus
2006-11-09

The University of the Free State has taken a step to address the need of black teachers in the country by offering a B Ed degree in the further education and training (FET) phase at its Qwaqwa Campus as from January 2007.
 
“The accredited B Ed qualification provides the opportunity to students to empower themselves to become professional teachers in secondary schools. It is also suitable for the training of expertise for education-related careers such as instructors and trainers,” said Dr Elias Malete, acting principal of the UFS Qwaqwa Campus.
 
According to Dr Malete, education in South Africa is heading for a disaster owing to the large-scale exodus of teachers combined with the low enrolment figures of prospective teachers.
 
“Approximately 19 000 teachers leave the teaching profession annually, while all the training institutions in the country only manage to produce 4 800 new entrants to the profession,” said Dr Malete.
 
 “Indications are that a considerable number of students, especially from KwaZulu-Natal, want to study education at the Qwaqwa Campus. The implementation of the course will also address the need for qualified teachers in the country and contribute to the sustainability of the campus,” said Dr Malete.
 
 “The duration of the B Ed is four years. Prospective students who do not meet the admission requirements may enroll for a one-year career preparation programme and successful completion will provide them with admission to the degree the following year. Prospective students with an M-score of 24-27 may enroll for an extended B Ed programme over a period of five years,” said Dr Malete.
 
Other education programmes that are offered at the Qwaqwa Campus include a B Ed Honors degree in Curriculum Studies, a B Ed Honors degree in Education Management and Leadership and a Postgraduate Certificate in Education (PGCE).
 
Prospective students may call (058) 718-5000 or visit the UFS web site at www.ufs.ac.za for more information. Applications for admission to this programme close on 30 November 2006.
 
Media release
Issued by: Lacea Loader
Media Representative
Tel:   (051) 401-2584
Cell: 083 645 2454
8 November 2006
 
 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept